skip navigation

Skip Nav

HIV/AIDS Clinical Trials

Clinical Trial Search Results

51 studies were found about ( enfuvirtide OR Fuzeon )

Prospective Evaluation Among Patients Infected by HIV 1 in Virological Failure Owing to Lack of Compliance, of the Benefit in Terms of Compliance of an Optimised Antiretroviral Treatment With Enfuvirtide (Fuzeon) Associated With Two Active Molecules

Condition: HIV1 Infection; HIV Infections

NCT ID: NCT00937729

Effect of an Enfuvirtide-based Anti-HIV Drug Regimen on Latent HIV Reservoirs in Treatment Naive Adults

Condition: HIV Infections

NCT ID: NCT00051831

Study of a New Anti-HIV Drug, T-20, in HIV-Infected Children

Condition: HIV Infections

NCT ID: NCT00001118

T-20 With Anti-HIV Combination Therapy for Patients With Prior Anti-HIV Drug Treatment and/or Drug Resistance to Each of the Three Classes of Approved Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00008528

T-20 in HIV Patients With Prior Drug Treatment and/or Resistance to Each of the Three Classes of Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00021554

HIV Maintenance Therapy With T-20 During HAART Interruption

Condition: HIV Infection

NCT ID: NCT00013884

T-20 Plus a Selected Anti-HIV Treatment in HIV-Infected Children and Adolescents

Condition: HIV Infections

NCT ID: NCT00022763

Efficacy and Tolerance of the Switch From Enfuvirtine to Raltegravir in Antiretroviral Therapy Regimen in HIV Patients With Undetectable Viral Load

Condition: HIV Infections

NCT ID: NCT00454337

Early Intensification of Antiretroviral Therapy Including Enfuvirtide in HIV-1-Related Progressive Multifocal Leucoencephalopathy (ANRS125)

Condition: Leukoencephalopathy, Progressive Multifocal; HIV Infections

NCT ID: NCT00120367

A Study of T-20 in HIV-Positive Adults

Condition: HIV Infections

NCT ID: NCT00002228

A Study to Compare Three Doses of T-20 When Given in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz to HIV-Infected Adults

Condition: HIV Infections

NCT ID: NCT00002239

Intensification With Enfuvirtide in Naive HIV-infected Patients (ANRS130)

Condition: HIV Infections; AIDS

NCT ID: NCT00302822

Fuzeon (Enfuvirtide) Early Access Program for Patients With HIV-1 Infection

Condition: HIV Infections

NCT ID: NCT00050856

Adding New Drugs for HIV Infected Patients Failing Current Therapy

Condition: HIV Infections

NCT ID: NCT00031044

ESP Study: A Study to Assess the Effect of Adding Fuzeon (Enfuvirtide) to an Antiretroviral Regimen in Fuzeon-Naive Patients With Sustained HIV Viral Suppression.

Condition: HIV Infections

NCT ID: NCT00461266

Treatment Intensification for HIV Infected Patients With Multi-Drug Resistant Virus

Condition: HIV Infections

NCT ID: NCT00102934

QUALITE Study - A Study of Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With Human Immunodeficiency Virus-1 (HIV-1) Infection

Condition: HIV Infections

NCT ID: NCT00232908

A Study Comparing the Efficacy and Safety of Once-Daily Fuzeon (Enfuvirtide) Dosing Versus the Currently Recommended Twice-Daily Dosing in Human Immunodeficiency Virus-Type 1 (HIV-1) Infected Patients

Condition: HIV Infections

NCT ID: NCT00089492

Study of Enfuvirtide in HIV-Positive Subjects

Condition: HIV Infections; AIDS

NCT ID: NCT00086710

Evaluating the Effect of CHanging EnfuvirtidE to Raltegravir in HIV Infected Subjects

Condition: HIV Infections

NCT ID: NCT00529243

BOSS Study: A Study of Fuzeon Using the Needle-Free Biojector 2000 in Patients With HIV-1 Infection

Condition: HIV Infections

NCT ID: NCT00337701

WAND Study - A Study to Evaluate Fuzeon (Enfuvirtide) Administered by a Needle-Free Injection Device in Patients With HIV.

Condition: HIV Infections

NCT ID: NCT00233883

BLQ Study: A Study of a Protease Inhibitor With Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With HIV-1.

Condition: HIV Infections

NCT ID: NCT00326963

INNOVE Study: A Study of 3 Months Induction With Fuzeon (Enfuvirtide) + Optimized Background (OB) Versus OB Alone in HIV-1 Infected Patients With Virological Failure.

Condition: HIV Infections

NCT ID: NCT00615134

A Study of Fuzeon (Enfuvirtide) With an Integrase Inhibitor Plus Optimized Background in Treatment-Experienced HIV-1 Infected Patients

Condition: HIV Infections

NCT ID: NCT00488059

An Observational Study of Induction Therapy With Fuzeon (Enfuvirtide) in Combination With Antiretroviral Drugs in Patients With HIV-1 Infection

Condition: HIV Infections

NCT ID: NCT01902615

Study of Valproic Acid to Treat HIV Infected Adults

Condition: HIV Infections

NCT ID: NCT00312546

Clinical Trial to Assess the Efficacy of Darunavir/Ritonavir (DRV/r), Etravirine (ETV) and Raltegravir (MK-0518) in HIV Patients With Resistant Viruses

Condition: HIV Infections

NCT ID: NCT00460382

A Study With TMC125 in Human Immunodeficiency Virus (HIV) Type 1 Infected Patients, Who Were Treated With TMC125 Arm in a Sponsor-Selected TMC125 Study

Condition: Human Immunodeficiency Virus Type 1

NCT ID: NCT00128830

Optimized Antiretroviral Therapy During Allogeneic Hematopoietic Stem Cell Transplantation in HIV-1 Individuals

Condition: HIV

NCT ID: NCT01836068

Pilot Study Evaluating Interruption of Enfuvirtide (Fuzeon, T20) in Patients With Enfuvirtide Resistance

Condition: HIV Infections

NCT ID: NCT00187551

A Study to Evaluate the Safety and Efficacy of Adding Enfuvirtide to Oral Highly Active Antiretroviral Therapy (HAART) in Human Immunodeficiency Virus (HIV) Patients With Prior Treatment Experience

Condition: HIV Infections

NCT ID: NCT00487188

HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)

Condition: HIV-Associated Lipodystrophy Syndrome; Cardiovascular Disease

NCT ID: NCT00192660

A Study to Evaluate of the Efficacy of Enfuvirtide During the Induction Phase of Therapy

Condition: HIV Infections

NCT ID: NCT00344760

A 48 Week Study Comparing Treatment With Saquinavir + Lopinavir/Ritonavir in Combination With Enfuvirtide HAART Versus Saquinavir + Lopinavir/Ritonavir + Other Nucleoside Combinations to See the Efficacy of These Treatments in Patients Infected With HIV-1

Condition: HIV Infection

NCT ID: NCT00100984

Cohort Study for Patients Using Fuzeon (Enfuvirtide)

Condition: HIV Infections; Antiretroviral Treatment

NCT ID: NCT00216359

Enfuvirtide/Current Protease Inhibitor Switch to PREZISTA (Darunavir)/Ritonavir + TMC125 in HIV Patients With Enfuvirtide Side Effects.

Condition: HIV

NCT ID: NCT00460746

Fuzeon Viral Decay Pilot Study

Condition: HIV-1

NCT ID: NCT00334022

Optimizing Treatment for Treatment-Experienced, HIV-infected People

Condition: HIV Infections

NCT ID: NCT00537394

Metabolic Effects of Enfuvirtide in Healthy Volunteers

Condition: HIV Infections

NCT ID: NCT00657761

Raltegravir in Patients With End Stage Liver Disease and in Transplant Recipients

Condition: HIV Infection; Liver Failure; Evidence of Liver Transplantation

NCT ID: NCT01022476

RAL-eve Study: Raltegravir Substitution Study

Condition: HIV Infections

NCT ID: NCT00523237

The Effects of Anti-HIV Therapy on the Immune Systems of Children and Young Adults Infected With HIV

Condition: HIV Infections

NCT ID: NCT00004735

Study to Assess Safety and Quality of Life of Patients Using Biojector Versus Needles for Fuzeon Administration

Condition: Human Immunodeficiency Virus

NCT ID: NCT00333736

SPRING: Safety, Efficacy, Pharmacokinetics of tipRanavir/r IN Race/Gender HIV+ Patients Randomized to TDM or SoC

Condition: HIV Infections

NCT ID: NCT00440271

Raltegravir With Optimized Background Therapy (OBT) in Multiple Experienced HIV-infected Patients

Condition: HIV Infections

NCT ID: NCT01190124

Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of Antiretroviral-Experienced NonCCR5-Tropic HIV-1 Infected Subjects

Condition: HIV Infections

NCT ID: NCT00098748

A Rollover Study to Provide Chronic T-1249 to Patients Who Completed Study T1249-102

Condition: HIV Infections

NCT ID: NCT00048217

Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)

Condition: Human Immunodeficiency Virus

NCT ID: NCT01814722

Clinical Trial of CNS-targeted HAART (CIT2)

Condition: HIV Infections

NCT ID: NCT00624195

Phase 3 Study of the Safety and Efficacy of Ritonavir-Boosted Elvitegravir (EVG/r) Versus Raltegravir (RAL)

Condition: HIV Infection

NCT ID: NCT00707733